Shekarlab, Nayereh team published research in Applied Organometallic Chemistry in 2020 | 6334-18-5

Related Products of 6334-18-5, 2,3-Dichlorobenzaldehyde(2,3-DBA)is a useful research compound. Its molecular formula is C7H4Cl2O and its molecular weight is 175.01 g/mol. The purity is usually 95%.
2,3-DBA is an organic compound that is used as a synthetic intermediate in the preparation of other chemicals. It is prepared by reacting 2-chloroacetophenone with hydrochloric acid and sodium carbonate in a reaction vessel. The product can be purified through fractional distillation or crystallization. The optical properties of 2,3-DBA are determined by its dipole moment and the substituents attached to the methylene group. Molecular modeling studies have shown that felodipine can bind to 2,3-DBA through its active methylene group. The reaction products between sulfadiazine and 2,3-DBA are pyridinedicarboxylic acid and 3-chlorobenzaldehyde.
2,3-DBA is part of a group of Benzaldehyde (B119740) derivatives that exhibit activity against Mycobacterium tuberculosis, the bacteria responsible for causing tuberculosis in humans. 2,3-DBA is also used as a reagent to synthesize (E)-2-(2-arylhydrazinyl)quinoxalines, compounds that have potent anticancer activity., 6334-18-5.

Organic chlorides are organic molecules with a C-Cl bond, for example chloroform (CH3-Cl) or vinyl chloride(C2H3Cl). 6334-18-5, formula is C7H4Cl2O, Name is 2,3-Dichlorobenzaldehyde. Organic chlorides can be used in production of: PVC, Organic chlorides can cause corrosion in pipelines, valves and condensers, and cause catalyst poisoning. Related Products of 6334-18-5.

Shekarlab, Nayereh;Ghorbani-Vaghei, Ramin;Alavinia, Sedigheh research published 《 Preparation and characterization of copper/polysulfonamide complex immobilized on graphene oxide as a novel catalyst for the synthesis of pyrimido[1,2-a]benzimidazoles》, the research content is summarized as follows. Copper-polysulfonamide complex immobilized on graphene oxide as a novel heterogeneous catalyst (GO@PSA-Cu) was synthesized and the structure and morphol. of catalyst were characterized with various anal. techniques such as Fourier-transform IR spectroscopy, SEM, energy-dispersive X-ray, N2 isotherms, elemental mapping, inductively coupled plasma-MS, and thermogravimetric anal. The GO@PSA-Cu catalyst demonstrated good to excellent yields for the synthesis new derivatives of pyrimido[1,2-a]benzimidazoles I (R = 2-OMe, 4-Cl, 2.3-di-Cl, etc.) via one-pot three-component condensation reaction of various aromatic aldehydes, 2-aminobenzimidazole, and Et acetoacetate in ethanol. The method presented herein has several prominent advantages such as cost-effectiveness, operational simplicity, short reaction times, high yields, and reusability of the catalyst even after six consecutive runs.

Related Products of 6334-18-5, 2,3-Dichlorobenzaldehyde(2,3-DBA)is a useful research compound. Its molecular formula is C7H4Cl2O and its molecular weight is 175.01 g/mol. The purity is usually 95%.
2,3-DBA is an organic compound that is used as a synthetic intermediate in the preparation of other chemicals. It is prepared by reacting 2-chloroacetophenone with hydrochloric acid and sodium carbonate in a reaction vessel. The product can be purified through fractional distillation or crystallization. The optical properties of 2,3-DBA are determined by its dipole moment and the substituents attached to the methylene group. Molecular modeling studies have shown that felodipine can bind to 2,3-DBA through its active methylene group. The reaction products between sulfadiazine and 2,3-DBA are pyridinedicarboxylic acid and 3-chlorobenzaldehyde.
2,3-DBA is part of a group of Benzaldehyde (B119740) derivatives that exhibit activity against Mycobacterium tuberculosis, the bacteria responsible for causing tuberculosis in humans. 2,3-DBA is also used as a reagent to synthesize (E)-2-(2-arylhydrazinyl)quinoxalines, compounds that have potent anticancer activity., 6334-18-5.

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics